Metabolic & Cardiometabolic · Gut & Microbiome
Can a gut-bacteria compound boost a blood-sugar hormone?
The claim, precisely: microbial indole increases GLP-1
Yes, but shown mainly in animals and lab models, not yet proven in people.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Microbial tryptophan-derived indole has a biphasic effect on per-cell GLP-1 (acute stimulation via Kv-channel block, chronic suppression via reduced ATP) but also expands L-cell number/differentiation; indole derivatives are inversely associated with human T2D risk. Animal/mechanism-grade.
The evidence (6)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Phuah P, et al. 2026 · Diabetologia | animal | supports | moderate | Indole enhanced GLP-1 secretion + L-cell differentiation, improved glucose (diabetic mouse) |
| Chimerel C, et al. 2014 · Cell Rep | in-vitro | mixed | moderate | [FT-verified] Chimerel indole biphasic acute-up chronic-down (mouse L-cells); biphasic=mixed |
| (indole-vagal) 2020 · (rat) | animal | supports | moderate | [FT-verified] indole 1mM stimulates colonic vagal afferents via GLP-1 L-cells; neural coupling. ANIMAL |
| Phuah P, et al. 2026 · Diabetologia | animal | supports | moderate | Sub-chronic indole improved glucose tolerance + drove L-cell differentiation in diabetic mice |
| Chimerel C, et al. 2014 · Cell Rep | animal | supports | high | Indole acutely stimulated but chronically suppressed L-cell GLP-1 (biphasic) |
| (indole-vagal) 2020 · (rat) | animal | supports | moderate | Indole-evoked L-cell GLP-1 activated colonic vagal afferents |
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.